hESC recipients must provide documentation of of ESCRO, IRB, or equivalent ethical review for the reseach planned with the requested line.
UCLA 7 (47, XX+13) was karyotyped at passage 7 after derivation. Cytogenic analysis of the resulting hESC line was performed on twenty G-banded metaphase cells and all twenty cells demonstrated trisomy 13. No other karyotypic abnormality was identified. Trisomy 13 is a genetic disorder also referred to as Patau syndrome.